Devices › Saline, vascular access flush
Device brand name · Saline vascular access flush
Bd Posiflush Normal Saline Syringe: medical device reports filed with FDA
529 reports name it, 2018–2023. Manufacturer given most often on reports: Bd Medical Bd West Medical Surgical. Product code NGT.
- 529
- device reports naming the brand
- 0% of all MAUDE reports · about 62 a year
- 0
- reports, 12 months to August 2026
- 0 in the 12 months before
- 97.9%
- classified as malfunction
- 88% across the product code
- 0%
- classified as death, as reported
- 0 reports · not verified by FDA
529 medical device reports received by FDA name the brand "Bd Posiflush Normal Saline Syringe" (saline vascular access flush); the manufacturer given most often on reports is Bd Medical Bd West Medical Surgical; received from January 2018 to October 2023. Brand names are as the reporter or manufacturer wrote them, so one product can appear under several spellings.
0 reports arrived in the 12 months to August 2026, and none in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (97.9%) and injury (2.1%); across all saline, vascular access flush reports (product code NGT) death is recorded in 0.7% and malfunction in 88%. Event type is the reporter's classification of the report, not a verified outcome.
The device problems coded most often are leak/splash (35.2%), failure to deliver (21.6%) and break (12.3%). The patient problems coded most often are no patient involvement, anaphylactic shock and hypersensitivity/allergic reaction. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Reports by month, five years
Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
By year received
Event type and report source
Event type, as classified on the report
Who filed the report
Grey bar: all 3,171 reports carrying product code NGT. Event type is the filer's classification and is not verified by FDA.
Device problems coded
| Device problem (FDA code) | Reports | Share | Share across product code |
|---|---|---|---|
| Leak/splashthe device leaked | 186 | 35.2% | 26.8% |
| Failure to deliverthe device did not deliver the dose or item | 114 | 21.6% | 12.1% |
| Breakthe device broke | 65 | 12.3% | 8.3% |
| Physical resistance/sticking | 58 | 11% | 3.9% |
| Device contamination with chemical or other material | 27 | 5.1% | 6.1% |
| Device markings/labelling problema problem with the device markings or label | 16 | 3% | 4.3% |
| Defective component | 15 | 2.8% | 2.6% |
| Fluid/blood leak | 14 | 2.6% | 1.9% |
| Crackthe device cracked | 10 | 1.9% | 2.1% |
| Device damaged prior to usethe device was damaged before use | 10 | 1.9% | 1.2% |
| Difficult to advance | 10 | 1.9% | 0.6% |
| Difficult to flush | 9 | 1.7% | 0.4% |
| Material separation | 9 | 1.7% | 2.2% |
| Material deformation | 8 | 1.5% | 1.2% |
| Missing information | 5 | 0.9% | 0.9% |
| Partial blockage | 5 | 0.9% | 0.3% |
| Complete blockage | 4 | 0.8% | 0.4% |
| Defective devicethe device was defective | 4 | 0.8% | 0.9% |
| Delivered as unsterile product | 4 | 0.8% | 0.5% |
| Detachment of device component | 4 | 0.8% | 0.3% |
FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.
Patient problems coded
| Patient problem (FDA code) | Reports | Share |
|---|---|---|
| No patient involvement | 17 | 3.2% |
| Anaphylactic shocka severe allergic reaction with collapse | 2 | 0.4% |
| Hypersensitivity/allergic reaction | 2 | 0.4% |
| Sweating | 2 | 0.4% |
| Vomitingbeing sick | 2 | 0.4% |
| Bacterial infectiona bacterial infection | 1 | 0.2% |
| Blood loss | 1 | 0.2% |
| Chemical exposure | 1 | 0.2% |
| Convulsion/seizure | 1 | 0.2% |
| Decreased level of consciousness | 1 | 0.2% |
| Discomfortdiscomfort | 1 | 0.2% |
| Dizzinesslight-headedness or unsteadiness | 1 | 0.2% |
| Dyspneashortness of breath | 1 | 0.2% |
| Edemaswelling from fluid | 1 | 0.2% |
| Fever | 1 | 0.2% |
Patient problem codes are present mainly in reports filed since 2019 and are often blank.
In context
| Measure | Bd Posiflush Normal Saline Syringe | Product code NGT | All MAUDE reports |
|---|---|---|---|
| Reports | 529 | 3,171 | 26,136,888 |
| Share of that pool | — | 16.7% | 0% |
| Classified as death, per 1,000 reports | 0 | 7 | 9 |
| Classified as injury | 2.1% | 8.8% | 36.2% |
| Classified as malfunction | 97.9% | 88% | 62.3% |
| Filed by the manufacturer | 99.6% | 89.4% | 94.9% |
Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Other brands with product code NGT
| Brand | Reports | Latest 12 months | Classified as death |
|---|---|---|---|
| 10 Ml Bd Posiflush Normal Saline Syringe | 253 | 0 | 0% |
| Bd Posiflush Syringe | 187 | 0 | 0.5% |
| Syringe 10ml Saline Fill China Sp | 162 | 21 | 0% |
| Syringe 5ml Saline Fill China Sp | 177 | 23 | 0% |
| Syringe 10ml Reg Pr Saline 10ml Fill | 156 | 0 | 0% |
| Monoject | 430 | 14 | 0.2% |
| B Braun | 270 | 12 | 3% |
| Unknown Prefill | 184 | 0 | 53.8% |
| Bd | 191 | 0 | 1% |
| Unspecified Bd Syringe | 926 | 0 | 0.1% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."
Questions about Bd Posiflush Normal Saline Syringe reports
How many FDA reports name Bd Posiflush Normal Saline Syringe?
529 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 0 in the latest 12 months.
What kinds of events are reported?
malfunction (97.9%) and injury (2.1%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.
What device problems are coded?
leak/splash (35.2%), failure to deliver (21.6%), break (12.3%), physical resistance/sticking (11%) and device contamination with chemical or other material (5.1%). These are FDA's device problem codes as entered on the report.
Who files these reports?
manufacturer reports (99.6%) and voluntary reports (0.2%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.
Do these reports show that Bd Posiflush Normal Saline Syringe was at fault?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."
How do I report a problem with a medical device?
Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.